Abstract
Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis.It strengthens the ARIA change management strategy in the prevention and managementof airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.
| Original language | English |
|---|---|
| Pages (from-to) | 168-190 |
| Number of pages | 23 |
| Journal | Allergy |
| Volume | 76 |
| Issue number | 1 |
| Early online date | 8 Jun 2020 |
| DOIs | |
| Publication status | Published - 7 Jan 2021 |
Keywords
- asthma
- digital transformation of health and care
- rhinitis
- MASK
- ARIA
- CARAT
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Fingerprint
Dive into the research topics of 'ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Allergy, Vol. 76, No. 1, 07.01.2021, p. 168-190.
Research output: Contribution to journal › Review article › peer-review
TY - JOUR
T1 - ARIA digital anamorphosis
T2 - Digital transformation of health and care in airway diseases from research to practice
AU - Bousquet, Jean
AU - Anto, Josep M.
AU - Bachert, Claus
AU - Haahtela, Tari
AU - Zuberbier, Torsten
AU - Czarlewski, Wienczyslawa
AU - Bedbrook, Anna
AU - Bosnic-Anticevich, Sinthia
AU - Walter Canonica, G.
AU - Cardona, Victoria
AU - Costa, Elisio
AU - Cruz, Alvaro A.
AU - Erhola, Marina
AU - Fokkens, Wytske J.
AU - Fonseca, Joao A.
AU - Illario, Maddalena
AU - CarlosIvancevich, Juan
AU - Jutel, Marek
AU - Klimek, Ludger
AU - Kuna, Piotr
AU - Kvedariene, Violeta
AU - Le, Ltt
AU - Larenas-Linnemann, Desiree
AU - Laune, Daniel
AU - Lourenço, Olga M.
AU - Melén, Eric
AU - Mullol, Joaquim
AU - Niedoszytko, Marek
AU - Odemyr, Mikaëla
AU - Okamoto, Yoshitaka
AU - Papadopoulos, Nikos G.
AU - Patella, Vincenzo
AU - Pfaar, Oliver
AU - Pham-Thi, Nhân
AU - Rolland, Christine
AU - Samolinski, Boleslaw
AU - Sheikh, Aziz
AU - Sofiev, Mikhail
AU - Suppli Ulrik, Charlotte
AU - Todo-Bom, Ana
AU - Tomazic, Peter V.
AU - Toppila-Salmi, Sanna
AU - Tsiligianni, Ioanna
AU - Valiulis, Arunas
AU - Valovirta, Erkka
AU - Ventura, Maria-Teresa
AU - Walker, Samantha
AU - Williams, Sian
AU - Yorgancioglu, Arzu
AU - Agache, Ioana
AU - Akdis, Cezmi A.
AU - Almeida, Rute
AU - Ansotegui, Ignacio J.
AU - Annesi-Maesano, Isabella
AU - Arnavielhe, Sylvie
AU - Basagaña, Xavier
AU - Bateman, Eric
AU - Bédard, Annabelle
AU - Bedolla-Barajas, Martin
AU - Becker, Sven
AU - Bennoor, Kazi S.
AU - Benveniste, Samuel
AU - Bergmann, Karl C.
AU - Bewick, Michael
AU - Bialek, Slawomir
AU - Billo, Nils
AU - Bindslev-Jensen, Carsten
AU - Bjermer, Leif
AU - Blain, Hubert
AU - Bonini, Matteo
AU - Bonniaud, Philippe
AU - Bosse, Isabelle
AU - Bouchard, Jacques
AU - Boulet, Louis P.
AU - Bourret, Rodolphe
AU - Boussery, Koen
AU - Braido, Fluvio
AU - Briedis, Vitalis
AU - Briggs, Andrew
AU - Brightling, Christopher E.
AU - Brozek, Jan
AU - Brusselle, Guy
AU - Brussino, Luisa
AU - Buhl, Roland
AU - Buonaiuto, Roland
AU - Calderon, Moises A.
AU - Camargos, Paolo
AU - Camuzat, Thierry
AU - Caraballo, Luis
AU - Carriazo, Ana Maria
AU - Carr, Warner
AU - Cartier, Christine
AU - Casale, Thomas
AU - Cecchi, Lorenzo
AU - Cepeda Sarabia, Alfonso M.
AU - Chavannes, Niels
AU - Chkhartishvili, Ekaterine
AU - Chu, Derek K.
AU - Cingi, Cemal
AU - Correia de Sousa, Jaime
AU - Costa, David J.
AU - Courbis, Anne Lise
AU - Custovic, Adnan
AU - Cvetkosvki, Biljana
AU - D'Amato, Gennaro
AU - da Silva, Jane
AU - Dantas, Carina
AU - Dokic, Dejan
AU - Dauvilliers, Yves
AU - De Feo, Giulia
AU - De Vries, Govert
AU - Devillier, Philippe
AU - Di Capua, Stefania
AU - Dray, Gerard
AU - Dubakiene, Ruta
AU - Durham, Stephen R.
AU - Dykewicz, Marc
AU - Ebisawa, Motohiro
AU - Gaga, Mina
AU - El-Gamal, Yehia
AU - Heffler, Enrico
AU - Emuzyte, Regina
AU - Farrell, John
AU - Fauquert, Jean-Luc
AU - Fiocchi, Alessandro
AU - Fink-Wagner, Antje
AU - Fontaine, Jean-François
AU - Fuentes Perez, José M.
AU - Gemicioğlu, Bilun
AU - Gamkrelidze, Amiran
AU - Garcia-Aymerich, Judith
AU - Gevaert, Philippe
AU - Gomez, Maximiliano
AU - González Diaz, Sandra
AU - Gotua, Maia
AU - Guldemond, Nick A.
AU - Guzmán, Maria-Antonieta
AU - Hajjam, Jawad
AU - Huerta Villalobos, Yunuen R.
AU - Humbert, Marc
AU - Iaccarino, Guido
AU - Ierodiakonou, Despo
AU - TomohisaIinuma, null
AU - Jassem, Ewa
AU - Joos, Guy
AU - Jung, Ki-Suck
AU - Kaidashev, Igor
AU - Kalayci, Omer
AU - Kardas, Przemyslaw
AU - Keil, Thomas
AU - Khaitov, Musa
AU - Khaltaev, Nikolai
AU - Kleine-Tebbe, Jorg
AU - Kouznetsov, Rostislav
AU - Kowalski, Marek L.
AU - Kritikos, Vicky
AU - Kull, Inger
AU - La Grutta, Stefania
AU - Leonardini, Lisa
AU - Ljungberg, Henrik
AU - Lieberman, Philip
AU - Lipworth, Brian
AU - Lodrup Carlsen, Karin C.
AU - Lopes-Pereira, Catarina
AU - Loureiro, Claudia C.
AU - Louis, Renaud
AU - Mair, Alpana
AU - Mahboub, Bassam
AU - Makris, Michaël
AU - Malva, Joao
AU - Manning, Patrick
AU - Marshall, Gailen D.
AU - Masjedi, Mohamed R
AU - Maspero, Jorge F.
AU - Carreiro-Martins, Pedro
AU - Makela, Mika
AU - Mathieu-Dupas, Eve
AU - Maurer, Marcus
AU - De Manuel Keenoy, Esteban
AU - Melo-Gomes, Elisabete
AU - Meltzer, Eli O.
AU - Menditto, Enrica
AU - Mercier, Jacques
AU - Micheli, Yann
AU - Miculinic, Neven
AU - Mihaltan, Florin
AU - Milenkovic, Branislava
AU - Mitsias, DimitiriosI
AU - Moda, Giuliana
AU - Mogica-Martinez, Maria-Dolores
AU - Mohammad, Yousser
AU - Montefort, Steve
AU - Monti, Ricardo
AU - Morais-Almeida, Mario
AU - Mösges, Ralph
AU - Münter, Lars
AU - Muraro, Antonella
AU - Murray, Ruth
AU - Naclerio, Robert
AU - Napoli, Luigi
AU - Namazova-Baranova, Leila
AU - Neffen, Hugo
AU - Nekam, Kristoff
AU - Neou, Angelo
AU - Nordlund, Björn
AU - Novellino, Ettore
AU - Nyembue, Dieudonné
AU - O'Hehir, Robyn
AU - Ohta, Ken
AU - Okubo, Kimi
AU - Onorato, Gabrielle L
AU - Ouedraogo, Solange
AU - Palamarchuk, Julia
AU - Pali-Schöll, Isabella
AU - Panzner, Peter
AU - Park, Hae-Sim
AU - Passalacqua, Gianni
AU - Pépin, Jean-Louis
AU - Paulino, Ema
AU - Phillips, Jim
AU - Picard, Robert
AU - Pinnock, Hilary
AU - Plavec, Davor
AU - Popov, Todor A.
AU - Portejoie, Fabienne
AU - Price, David
AU - Prokopakis, Emmanuel P.
AU - Psarros, Fotis
AU - Pugin, Benoit
AU - Puggioni, Francesca
AU - Quinones-Delgado, Pablo
AU - Raciborski, Filip
AU - Rajabian-Söderlund, Rojin
AU - Regateiro, Frederico S.
AU - Reitsma, Sietze
AU - Rivero-Yeverino, Daniele
AU - Roberts, Graham
AU - Roche, Nicolas
AU - Rodriguez-Zagal, Erendira
AU - Rolland, Christine
AU - Roller-Wirnsberger, Regina E
AU - Rosario, Nelson
AU - Romano, Antonino
AU - Rottem, Menahem
AU - Ryan, Dermot
AU - Salimäki, Johanna
AU - Sanchez-Borges, Mario M.
AU - Sastre, Joaquin
AU - Scadding, Glenis K
AU - Scheire, Sophie
AU - Schmid-Grendelmeier, Peter
AU - Schünemann, Holger J.
AU - Serpa, FaradibaSarquis
AU - Shamji, Mohamed
AU - Sisul, Juan-Carlos
AU - Sofiev, Mikhail
AU - Solé, Dirceu
AU - Somekh, David
AU - Sooronbaev, Talant
AU - Sova, Milan
AU - Spertini, François
AU - Spranger, Otto
AU - Stellato, Cristiana
AU - Stelmach, Rafael
AU - Thibaudon, Michel
AU - To, Teresa
AU - MondherToumi, null
AU - Usmani, Omar
AU - Valero, AntonioA
AU - Valenta, Rudolph
AU - Valentin-Rostan, Marylin
AU - van der Kleij, Rianne
AU - Van Eerd, Michiel
AU - Vandenplas, Olivier
AU - Vasankari, Tuula
AU - Vaz Carneiro, Antonio
AU - Vezzani, Giorgio
AU - Viart, Frédéric
AU - Viegi, Giovanni
AU - Wallace, Dana
AU - Wagenmann, Martin
AU - Wang, De Yun
AU - Waserman, Susan
AU - Wickman, Magnus
AU - Williams, Dennis M.
AU - Wong, Gary
AU - Wroczynski, Piotr
AU - Yiallouros, Panayiotis K.
AU - Yusuf, Osman M.
AU - Zar, Heather J.
AU - Zeng, Stéphane
AU - Zernotti, Mario E.
AU - Zhang, Luo
AU - Zhong, Nan Shan
AU - Zidarn, Mihaela
N1 - Funding Information: MA reports personal fees from POCI‐01‐0145‐FEDER‐029130 mINSPIRERS—mHealth to measure and improve adherence to medication in chronic obstructive respiratory diseases—generalization and evaluation of gamification, peer support and advanced image processing technologies from ERDF (European Regional Development Fund) funded by the COMPETE2020 and by National Funds through FCT (Fundação para a Ciência e a Tecnologia). EB reports personal fees from Novartis, Menarini, ALK, Sanofi Regeneron, Boehringer Ingelheim, AstraZeneca, Sanofi Genzyme, Orion, and is a member of the Science Committee and Board of the Global Initiative for Asthma (GINA). PB reports personal fees and other from Roche, Boehringer and Novartis, personal fees from AstraZeneca and TEVA, and other from Chiesi and Stallergenes. LPB reports research grants for participation to multicentre studies from AstraZeneca, Boston Scientific, GlaxoSmithKline, Hoffman La Roche, Novartis, Ono Pharma, Sanofi and Takeda, support for research projects introduced by the investigator from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck and Takeda, fee for consulting and advisory boards from Astra Zeneca, Novartis and Methapharm, nonprofit grants for production of educational materials from AstraZeneca, Boehringer‐Ingelheim, GlaxoSmithKline, Merck and Novartis, conference fees from AstraZeneca, GlaxoSmithKline, Merck and Novartis, and support for participation in conferences and meetings from Novartis and Takeda. JB reports personal fees from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Purina, Sanofi Aventis, Takeda, Teva, and Uriach, and other from KYomed INNOV. RB reports personal fees from AstraZeneca, Chiesi, Cipla, Sanofi and Teva, grants and personal fees from Boehringer Ingelheim, Novartis and Roche, and grants from GlaxoSmithKline, all outside the submitted work. VC reports personal fees from ALK, Allergopharma, Allergy Therapeutics, Diater, LETI, Thermo Fisher and Stallergenes. JCS reports other from Boehringer Ingelheim, GSK, personal fees, nonfinancial support and other from AstraZeneca, personal fees and other from Mundipharma. AC reports personal fees from Novartis, Regeneron, Thermo Fisher Scientific, Philips and Sanofi. ME reports personal fees from DBV Technologies and Mylan. JF reports being a partner in a company developing mobile technologies for monitoring airways diseases. EH reports personal fees from AstraZeneca, Novartis, GSK, Sanofi Genzyme, Teva, Circassia and Nestlè Purina. GI is consultant for Amicus Therapeutics and received a research grant from Amicus therapeutics. PK reports personal fees from Aflofarm, Fresenius, Lek‐AM, Novartis, Polpharma and Sandoz, grants from European Union, European Commission. LK reports personal fees from Allergopharma, HAL Allergie, ALK‐Abelló, LETI Pharma, Allergy Therapeutics, Stallergenes, Quintiles, AstraZeneca, GSK, ASIT biotech and Lofarma, and grants and personal fees from MEDA/Mylan and Sanofi. DLL reports personal fees from Armstrong, Astrazeneca, Boehringer Ingelheim, Chiesi, DBV Technologies, Grunenthal, GSK, MEDA, Menarini, MSD, Novartis, Pfizer, Novartis, Sanofi, Siegfried and UCB, grants from Sanofi, Astrazeneca, Novartis, UCB, GSK, TEVA, Boehringer Ingelheim and Chiesi. RL reports grants and personal fees from GSK, from AZ and Novartis and grants from Chiesi. Dr Loureiro reports personal fees from AstraZeneca, Novartis, GSK, Sanofi, TEVA and Menarini. JM reports personal fees and nonfinancial support from Novartis, Sanofi, AstraZeneca and Immunotek. MM reports grants and personal fees from Aralez, AstraZeneca, FAES, Genentech, Novartis, MSD, Roche, Sanofi, UCB and Uriach. JM reports personal fees from ALK‐Abelló, Sanofi Genzyme & Regeneron, Menarini Group, MSD, Mitsubishi‐Tanabe, Novartis, UCB Pharma, and GENENTECH—Roche, grants and personal fees from URIACH Group, MYLAN‐MEDA Pharma. AM reports personal fees from Aimmune, DVB, Nestlè Health Institute and Nestlè Purina. BN reports other from Co‐founded AsthmaTuner, eHealth system for asthma. YO reports personal fees from Kyowa Co., Ltd, Eizai Co., Ltd, Shionogi Co., Ltd., Torii Co., Ltd., GSK and MSD, grants and personal fees from Kyorin Co., Ltd., and Tiho Co., Ltd., grants from Yakuruto Co., Ltd., and Yamada Bee Farm. NP reports personal fees from Novartis, Nutricia, HAL, MENARINI/FAES FARMA, Sanofi, Mylan/Meda, BIOMAY, AstraZeneca, GSK, MSD, ASIT BIOTECH and Boehringer Ingelheim, and grants from Gerolymatos International SA and Capricare. JLP reports grants and personal fees from Air Liquide Foundation, Agiradom, AstraZeneca, Philips and ResMed, grants from Fisher and Paykel, Mutualia and Vitalaire, personal fees from Boehringer Ingelheim, Jazz pharmaceutical, Night Balance and Sefam. DP reports personal fees, nonfinancial support and other from Revenio, grants and personal fees from GlaxoSmithKline, personal fees from Merck and Sandoz, other from Boehringer Ingelheim, Novartis, MSD and Chiesi, nonfinancial support from Menarini, nonfinancial support from Pharmas, and personal fees and nonfinancial support from Salveo. DP reports personal fees from Amgen, Mundipharma, Novartis, Pfizer, Regeneron Pharmaceuticals, Cipla, GlaxoSmithKline, Kyorin and Thermo Fisher, grants and personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Circassia and Mylan, grants from Respiratory Effectiveness Group, Sanofi Genzyme, Teva and Theravance, grants from UK National Health Service, nonfinancial support from Efficacy and Evaluation Mechanism Programme, Health Technology Assessment and stock/stock options from AKL Research and Development Ltd which produces phytopharmaceuticals, and owns 74% of the social enterprise Optimum Patient Care Ltd (Australia and UK) and 74% of Observational and Pragmatic Research Institute Pte Ltd (Singapore). FP has been scientific consultant, researcher and speaker supported by the following commercial companies: Menarini, Alk‐Abello, Almirall, Allergy Therapeutics, Anallergo, AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GSK, Hal Allergy, Lab. Guidotti, Lofarma, Malesci, MSD, Mundipharma, Novartis, Roche, Sanofi, Stallergenes and Valea. Dr Sastre is consultant for Thermo Fisher, Hycor, Novartis, Sanofi, Leti, Mundipharma, ALK and GSK, paid conferences from Novartis, GSK, Circassia, Sanofi, LETI and FAES FARMA, and research grants from Thermo Fisher, Mundipharma, ALK, Sanofi. GS reports personal fees from ALK, Mylan and ALK and other from Rhinology & Laryngology Research Fund, BSACI and EAACI. MS reports fees from ASIT Biotech.sa, ALK and Allergopharma. AMTB reports grants and personal fees from Novartis, Sanofi, Mundipharma, GSK (GlaxoSmithKline) and Teva Pharma, personal fees from AstraZeneca, grants from Boehringer Ingelheim, outside the submitted work. IT reports personal fees from Honoraria for educational activities, speaking engagements, advisory boards from Boehringer Ingelheim, Astra Zeneca, GSK and Novartis and grants from GSK Hellas and Elpen. MW reports personal fees from ALK‐Abello, AstraZeneca, Bencard Allergie, HAL Allergy, Leti Pharma, Meda Pharma, Novartis, Sanofi Aventis, Stallergenes and Teva. SW reports personal fees and other from CSL Behring, Shire, AstraZeneca, Teva, Meda, Merck, GSK and Novartis, personal fees from Pediapharm, Aralez, Sanofi and Stallergenes. The other authors have no conflict of interest to declare. Publisher Copyright: © 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
PY - 2021/1/7
Y1 - 2021/1/7
N2 - Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis.It strengthens the ARIA change management strategy in the prevention and managementof airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.
AB - Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis.It strengthens the ARIA change management strategy in the prevention and managementof airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.
KW - asthma
KW - digital transformation of health and care
KW - rhinitis
KW - MASK
KW - ARIA
KW - CARAT
UR - http://www.scopus.com/inward/record.url?scp=85093537037&partnerID=8YFLogxK
U2 - 10.1111/all.14422
DO - 10.1111/all.14422
M3 - Review article
C2 - 32512619
SN - 0105-4538
VL - 76
SP - 168
EP - 190
JO - Allergy
JF - Allergy
IS - 1
ER -